These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4351588)

  • 1. Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis.
    Adler A; Morse SI
    Infect Immun; 1973 Mar; 7(3):461-7. PubMed ID: 4351588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.
    MORSE SI
    J Exp Med; 1965 Jan; 121(1):49-68. PubMed ID: 14253487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
    Meade BD; Kind PD; Manclark CR
    Infect Immun; 1984 Dec; 46(3):733-9. PubMed ID: 6094357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis.
    Taub RN; Rosett W; Adler A; Morse SI
    J Exp Med; 1972 Dec; 136(6):1581-93. PubMed ID: 4345107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bordetella pertussis leukocytosis (lymphocytosis)-promoting factor (LPF) on the physical lymphoepithelial-cell association studied with the use of an in vitro model of mouse thymus.
    Sugimoto M; Nakanishi Y; Otokawa M; Uchida N; Yasuda T; Sato H; Sato Y
    J Immunol; 1983 Jun; 130(6):2767-74. PubMed ID: 6682875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response.
    Kong AS; Morse SI
    J Exp Med; 1977 Jan; 145(1):151-62. PubMed ID: 187715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis.
    Meade BD; Kind PD; Manclark CR
    Dev Biol Stand; 1985; 61():63-74. PubMed ID: 2872133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytosis-promoting factor of Bordetella pertussis: isolation, characterization, and biological activity.
    Morse SI
    J Infect Dis; 1977 Aug; 136 Suppl():S234-8. PubMed ID: 197175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. 3. The distribution of transfused lymphocytes in pertussis-treated and normal mice.
    Morse SI; Barron BA
    J Exp Med; 1970 Oct; 132(4):663-72. PubMed ID: 4323778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.
    Kong AS; Morse SI
    J Exp Med; 1977 Jan; 145(1):163-74. PubMed ID: 187716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed type hypersensitivity induced by LPF from Bordetella pertussis.
    Guadalupe Cortés JM; Juliano Y; Mendes NF; Mendes E
    Allergol Immunopathol (Madr); 1986; 14(4):311-7. PubMed ID: 2877558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. I. Radioautographic analysis of the circulating cells in mice undergoing pertussis-induced hyperleukocytosis.
    Morse SI; Riester SK
    J Exp Med; 1967 Mar; 125(3):401-8. PubMed ID: 4289293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.
    Morse JH; Kong AS; Lindenbaum J; Morse SI
    J Clin Invest; 1977 Sep; 60(3):683-92. PubMed ID: 197121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of heat-labile toxin of B. pertussis on mouse blood cells: the determination of LPF (leukocytosis-promoting factor)].
    Ishida S; Kurokawa M
    Igaku To Seibutsugaku; 1972 Apr; 84(4):255-9. PubMed ID: 4340315
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis.
    Torre D; Quadrelli C; Pugliese A; Maggiolo F
    J Infect Dis; 1986 Aug; 154(2):238-44. PubMed ID: 3722864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytosis induced in mice by supernatant fluids of Bordetella pertussis cultures: a histopathological study.
    Athanassiades TJ; Morse SI
    Blood; 1973 Oct; 42(4):611-21. PubMed ID: 4360363
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD; Kind PD; Ewell JB; McGrath PP; Manclark CR
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1973 Jun; 7(6):992-9. PubMed ID: 4351972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.